Oridonin Inhibits Mycobacterium marinum Infection-Induced Oxidative Stress In Vitro and In Vivo.
Guangxin ChenZiyue YangDa WenPing LiQiuhong XiongChangxin WuPublished in: Pathogens (Basel, Switzerland) (2023)
Prior to the COVID-19 pandemic, tuberculosis (TB) was the leading cause of death globally attributable to a single infectious agent, ranking higher than HIV/AIDS. Consequently, TB remains an urgent public health crisis worldwide. Oridonin (7a,20-Epoxy-1a,6b,7,14-tetrahydroxy-Kaur-16-en-15-one Isodonol, C 20 H 28 O 6 , Ori), derived from the Rabdosia Rrubescens plant, is a natural compound that exhibits antioxidant, anti-inflammatory, and antibacterial properties. Our objective was to investigate whether Ori's antioxidant and antibacterial effects could be effective against the infection Mycobacterium marinum ( Mm )-infected cells and zebrafish. We observed that Ori treatment significantly impeded Mm infection in lung epithelial cells, while also suppressing inflammatory response and oxidative stress in Mm -infected macrophages. Further investigation revealed that Ori supplementation inhibited the proliferation of Mm in zebrafish, as well as reducing oxidative stress levels in infected zebrafish. Additionally, Ori promoted the expression of NRF2/HO-1/NQO-1 and activated the AKT/AMPK-α1/GSK-3β signaling pathway, which are both associated with anti-inflammatory and antioxidant effects. In summary, our results demonstrate that Ori exerts inhibitory effects on Mm infection and proliferation in cells and zebrafish, respectively. Additionally, Ori regulates oxidative stress by modulating the NRF2/HO-1/NQO-1 and AKT/AMPK-α1/GSK-3β signaling pathways.
Keyphrases
- signaling pathway
- induced apoptosis
- oxidative stress
- anti inflammatory
- pi k akt
- cell cycle arrest
- mycobacterium tuberculosis
- hiv aids
- public health
- epithelial mesenchymal transition
- inflammatory response
- diabetic rats
- dna damage
- ischemia reperfusion injury
- skeletal muscle
- cell proliferation
- endoplasmic reticulum stress
- poor prognosis
- single cell
- emergency department
- human immunodeficiency virus
- cell death
- replacement therapy